has launched new study using EEG neurofeedback as a therapy to manage neuropathic pain in the United Kingdom.
Funded by , the new trial is being led by researchers from the East Kent Hospitals University NHS Foundation Trust.
Researchers are currently recruiting for ten patients who, over a 22 week period, will wear an Axon EEG headset and learn to ‘retrain’ how their brain perceives and responds to pain.
All 10 participants have been recruited for the East Kent trial, which follows the completion of the world’s largest clinical trial in New Zealand. The study, led by researchers from the Auckland University of Technology (AUT) and the District Health Board ( DHB), showed significant reductions in patients’ pain, improved mental health and better sleep. The results of the trial are expected to be published in early 2023.